Matches in Nanopublications for { ?s ?p "[The discovery of JAK2 and MPL mutations in patients with myeloproliferative neoplasms (MPNs) provided important insight into the genetic basis of these disorders and led to the development of JAK2 kinase inhibitors for MPN therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP300252.RAamrbe_RPqe1DfbSwzvC5FZ5HgPgC2Q5jLcScjbC70gk130_assertion description "[The discovery of JAK2 and MPL mutations in patients with myeloproliferative neoplasms (MPNs) provided important insight into the genetic basis of these disorders and led to the development of JAK2 kinase inhibitors for MPN therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP300252.RAamrbe_RPqe1DfbSwzvC5FZ5HgPgC2Q5jLcScjbC70gk130_provenance.
- NP501378.RAO-f6KIokurzQ4FRl59lWc4x5nk_gV4r2sSDNLXT83bk130_assertion description "[The discovery of JAK2 and MPL mutations in patients with myeloproliferative neoplasms (MPNs) provided important insight into the genetic basis of these disorders and led to the development of JAK2 kinase inhibitors for MPN therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP501378.RAO-f6KIokurzQ4FRl59lWc4x5nk_gV4r2sSDNLXT83bk130_provenance.
- assertion description "[The discovery of JAK2 and MPL mutations in patients with myeloproliferative neoplasms (MPNs) provided important insight into the genetic basis of these disorders and led to the development of JAK2 kinase inhibitors for MPN therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The discovery of JAK2 and MPL mutations in patients with myeloproliferative neoplasms (MPNs) provided important insight into the genetic basis of these disorders and led to the development of JAK2 kinase inhibitors for MPN therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The discovery of JAK2 and MPL mutations in patients with myeloproliferative neoplasms (MPNs) provided important insight into the genetic basis of these disorders and led to the development of JAK2 kinase inhibitors for MPN therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.